Results

Total Results: 13 records

Showing results for "end stage renal".

  1. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_Data_Requirements_Statin_CVD_Patient_Facing.xlsx
    January 01, 2024 - active' OR 'relapse' Mixed (1 single code and 1 VS) 2.16.840.1.113762.1.4.1032.96 ICD-10-CM: Z99.2 EndStage Renal Disease Condition code verificationStatus is 'confirmed' clinicalStatus is 'active' OR … 'relapse' no abatement[x]attributes are present Single VS 2.16.840.1.113883.3.526.3.353 End Stage RenalStage Renal Disease Condition code verificationStatus is 'confirmed' clinicalStatus is 'active', 'relapse … Stage Renal Disease Encounter Encounter status is 'completed' reasonCode period Single VS 2.16.840.1.113883.3.464.1003.109.11.1029
  2. cds.ahrq.gov/sites/default/files/workgroups/226/mar-2017-cholesterol-wg-notes.docx
    January 01, 2017 - For example: · Out-of-range LDL result – substitute with the closest end range value and display the … most conservative guideline, etc. · Statin therapy exclusions: · Pregnant, breastfeeding, cirrhosis, endstage renal disease, and hemodialysis patients should be categorically excluded.
  3. cds.ahrq.gov/sites/default/files/workgroups/246/jul-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Dialysis is an exclusion (i.e., diagnosis of end stage renal disease or dialysis in the last seven days … Stage the order for the ultrasound so the doctors can sign. 0.
  4. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
    October 01, 2017 - medications, who are receiving palliative care, who have hepatic disease or insufficiency, who have end-stagerenal disease, and whose most recent LDL-c result is <70 mg/dL are excepted—that is, they are counted … Value sets needed to be established for computable definitions of ASCVD, end-stage renal disease, hepatic … Patients with end-stage renal disease (ESRD). … However, end users can adjust the notification text and the intensity of statin that is expressed in
  5. cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
    October 01, 2017 - Exclude patients with end-stage renal disease and patients undergoing dialysis. 4. … 50 11.79 190 45                 +           TRUE TRUE EndStage Renal Disease female 50 11.79 190 45                   +         TRUE TRUE … Management Work Group recommendation based on their medical expertise) Verify completeness Diagnosis of EndStage Renal Disease (ESRD) added as an Exclusion Statins are not indicated for individuals who are
  6. cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
    January 01, 2024 - Patient has end-stage renal disease. e. Patient is on another anticoagulant. 6 f. … provides an ability to track changes.4 With these functions entering common use among the various end … GI) bleed OR diagnosis of active GI ulcers OR diagnosis of bleeding disorders OR diagnosis of endstage renal disease (ESRD) OR dialysis within the past 7 days OR diagnosis of cirrhosis OR MOST … bleeding OR history of peptic ulcer disease OR diagnosis of bleeding disorders OR diagnosis of renal
  7. cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
    January 01, 2003 - failure, unspecified 313092 Sorbitol 700 MG/ML Oral Solution N18.1 Chronic kidney disease, stage … ) 314087 Magnesium Hydroxide 240 MG/ML Oral Suspension N18.4 Chronic kidney disease, stage 4 … (severe) 314113 Magnesium Oxide 200 MG Oral Tablet N18.5 Chronic kidney disease, stage 5 … Aluminum Hydroxide 200 MG / Magnesium Hydroxide 200 MG / Simethicone 20 MG Chewable Tablet N18.6 Endstage renal disease 317120 Magnesium Oxide 600 MG / Vitamin B6 25 MG Oral Tablet N18.9 Chronic
  8. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - additional scenarios that drive preventive health efforts across varied organizations, workflows, end … • A diagnosis of end stage renal disease (ESRD) or receiving dialysis therapy. … • Depending on the end user that will be interacting with the CDS (as well as the intervention action … Stage Renal Disease X Condition code verificationStatus is ‘confirmed’ clinicalStatus is ‘active … ’ no abatement[x] attributes are present End Stage Renal Disease Encounter X Encounter status
  9. cds.ahrq.gov/sites/default/files/cds/artifact/476/EnhancementofCDSArtifact%20BasedonPilotImplementation10012018.pdf
    December 01, 2018 - Community Health Information Network (OCHIN) Pilot Project Team • Pilot site leadership and clinician end … Both organizations collaborated on refinements to the CDS during every stage of the partnership to improve … end-of-life care (also described as hospice care and palliative care). … include: depression, anxiety, substance use disorder, suicide attempt, sleep-disordered breathing, renal … of accurate CDS interventions. 15 Enhancements that occurred during this stage
  10. cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
    October 01, 2017 - Patient has end-stage renal disease. e. Patient is on another anticoagulant. f. … Figure 1: CDS Artifact Maturity Process To continue the maturation of this artifact to the structured stage … Diagnosis of GI bleed OR Diagnosis of GI ulcers OR Diagnosis of bleeding disorders OR Diagnosis of renal
  11. cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2024 - Report with the artifact to describe CDS integration, testing, and implementation details, along with end-user … additional scenarios that drive preventive health efforts across varied organizations, workflows, end … • A diagnosis of end stage renal disease (ESRD) or receiving dialysis therapy. … • Depending on the end user who will be interacting with the CDS (as well as the intervention action … Impaired renal function may influence statin safety.4 For this reason, evidence of ESRD is listed as
  12. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
    January 01, 2024 - Report with the artifact to describe CDS integration, testing, and implementation details, along with end-user … additional scenarios that drive preventive health efforts across varied organizations, workflows, end … A diagnosis of end stage renal disease (ESRD) or receiving dialysis therapy. f. … • Depending on the end user who will be interacting with the CDS (as well as the intervention action … Impaired renal function may influence statin safety.12 For this reason, evidence of ESRD is listed as
  13. cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2024 - Report with the artifact to describe CDS integration, testing, and implementation details, along with end-user … disease or hepatic disease or insufficiency, who have statin-associated muscle symptoms, who have end-stagerenal disease (ESRD), or who have documentation of a medical reason for not being prescribed statin … • Depending on the end user who will be interacting with the CDS (as well as the intervention action … different strength statin for different patient groups are not implemented in this artifact; nevertheless, end

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: